Hepatitis B in Pakistan continues to pose a major public health challenge despite the availability of a safe and effective vaccine. Millions of people are living with chronic hepatitis B, while many remain unaware of their infection because the disease often develops without noticeable symptoms during its early stages.
By the time many patients seek medical attention, serious liver damage may already have occurred. Pakistan has taken important steps to strengthen childhood immunisation, improve blood safety, and expand hepatitis awareness campaigns. However, new infections continue to occur due to gaps in vaccination coverage, delayed diagnosis, and unsafe healthcare practices.
Ending hepatitis B requires a comprehensive approach that combines prevention, early detection, public education, and accessible treatment. With coordinated efforts from healthcare providers, government institutions, charitable organisations, and local communities, Pakistan can move closer to eliminating this preventable disease.
What Is Hepatitis B and Why Does It Remain a Public Health Concern?
Hepatitis B is a viral infection caused by the Hepatitis B virus (HBV), which primarily attacks the liver. While many adults recover completely after an acute infection, some people develop chronic hepatitis B, meaning the virus remains in their body for many years or throughout their lifetime.
Chronic hepatitis B increases the risk of developing:
- Liver cirrhosis
- Liver failure
- Hepatocellular carcinoma (liver cancer)
- Premature death from liver-related complications
The virus spreads through contact with infected blood or certain body fluids. Common routes of transmission include:
- Mother-to-child transmission during childbirth
- Unsafe blood transfusions
- Reuse of contaminated syringes
- Unsterilized surgical and dental instruments
- Unsafe tattooing or body piercing procedures
- Unprotected sexual contact with an infected person
Unlike several other chronic liver diseases, hepatitis B can be prevented through vaccination, making prevention one of the most effective public health strategies available.
Hepatitis B in Pakistan: Latest Statistics and National Disease Burden
The burden of Hepatitis B in Pakistan remains substantial. In Pakistan, there are estimated 7-9 million carriers of hepatitis B virus (HBV) with a carrier rate of 3-5%.
Important: If the number of hepatitis B and hepatitis C cases are combined, then Pakistan ranks fifth in the world.
These figures demonstrate that hepatitis B continues to affect thousands of families every year despite being largely preventable.
Earlier national studies conducted across Pakistan reported an overall hepatitis B prevalence of approximately 2.5%, highlighting the long-standing burden of the disease and the need for sustained prevention efforts.
The disease affects both urban and rural populations, although people living in underserved districts often face greater barriers to screening, diagnosis, vaccination, and treatment due to limited healthcare infrastructure.
Why Hepatitis B Continues to Affect Millions of Pakistanis
Several interconnected challenges continue to drive the spread of hepatitis B across Pakistan.
Limited Public Awareness
Many people are unfamiliar with how hepatitis B spreads or how it can be prevented. Since early infection rarely causes noticeable symptoms, individuals often delay testing until complications develop.
Delayed Diagnosis
Because hepatitis B can remain silent for many years, countless individuals are unaware they are infected. Early diagnosis allows patients to receive medical monitoring and treatment before permanent liver damage occurs.
Unsafe Healthcare Practices
Pakistan has made progress in improving infection prevention; however, unsafe injection practices, inadequate sterilisation of medical equipment, and poor infection control procedures still occur in certain healthcare settings. Continued monitoring and training remain essential.
Unequal Access to Healthcare
Healthcare facilities offering hepatitis screening, specialist consultations, and antiviral treatment are concentrated in larger cities. Many rural communities have limited access to diagnostic laboratories and liver specialists.
Stigma and Social Barriers
Fear of discrimination discourages some individuals from seeking testing or informing family members about their diagnosis. Reducing stigma is an important part of improving public health outcomes.
How Vaccination and Safe Healthcare Practices Can Prevent Hepatitis B?
One of the greatest advantages in the fight against hepatitis B is the availability of a highly effective vaccine.
The World Health Organisation recommends that every child receive a hepatitis B birth dose as soon as possible after delivery, followed by the complete routine vaccination schedule during infancy. High vaccination coverage has reduced new infections in many countries and remains one of the most cost-effective public health interventions.
Additional preventive measures include:
- Universal screening of donated blood
- Safe injection practices in healthcare facilities
- Proper sterilisation of surgical and dental instruments
- Screening pregnant women for hepatitis B
- Vaccinating newborns born to infected mothers
- Community awareness and education campaigns
- Regular testing for individuals at increased risk
Strengthening these preventive measures can reduce transmission and protect future generations.
Why Early Screening and Timely Treatment Save Lives
Early diagnosis offers the best opportunity to prevent severe liver disease.
People diagnosed before complications develop can benefit from regular liver monitoring, antiviral therapy when appropriate, and medical advice that lowers the risk of cirrhosis and liver cancer. Early treatment also helps healthcare providers monitor disease progression and identify complications before they become life-threatening.
Routine hepatitis screening should be encouraged for healthcare workers, pregnant women, family members of infected individuals, blood donors, and anyone with known exposure to unsafe medical procedures or blood products.
Expanding access to affordable screening services is an essential step toward reducing the burden of Hepatitis B in Pakistan.
Supporting the United Nations Sustainable Development Goals
Efforts to combat Hepatitis B in Pakistan directly contribute to the United Nations Sustainable Development Goal (SDG) 3: Good Health and Well-being, particularly Target 3.3, which aims to end the epidemics of viral hepatitis and other communicable diseases by 2030.
Improving vaccination coverage, strengthening disease surveillance, increasing access to healthcare, and promoting public awareness also support universal health coverage and healthier communities across Pakistan.
Achieving these goals requires collaboration between governments, healthcare institutions, development partners, charities, and local communities.
How UK Association of Medical Aid to Pakistan (UKMAP) Is Helping Communities Prevent Hepatitis B
UKMAP believes that no family should suffer from a disease that can often be prevented through awareness, vaccination, and timely medical care.
The organisation works alongside healthcare professionals and community partners to improve access to hepatitis prevention and care by:
- Organising free hepatitis B screening camps
- Supporting vaccination initiatives for vulnerable populations
- Conducting community health awareness sessions
- Promoting safe healthcare practices
- Facilitating referrals for diagnosis and treatment
- Expanding healthcare outreach in underserved areas
Through these initiatives, UK Association of Medical Aid to Pakistan supports healthier communities while contributing to Pakistan’s progress toward achieving the United Nations Sustainable Development Goals.
Building a Future Free from Hepatitis B in Pakistan
Although hepatitis B remains a serious health challenge, it is also one of the most preventable infectious diseases affecting Pakistan today. Vaccination, early diagnosis, safe healthcare practices, and public education have already transformed hepatitis control in many parts of the world, and Pakistan has the opportunity to build on this progress.
Reducing the burden of Hepatitis B in Pakistan requires sustained commitment from government agencies, healthcare providers, charitable organisations, and the public. Every vaccination administered, every patient screened, and every awareness campaign delivered brings the country one step closer to a future where hepatitis B is no longer a major public health threat.